ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

BPC-157 (Immune)

BPC-157 (Immune)

Also known as: BPC, Bepecin, PL 14736

Overview

Key Facts

Primary Goal: Research and therapeutic applications of BPC-157 (Immune)

Modulates nitric oxide pathways involved in immune signaling. Reduces TNF-alpha and other pro-inflammatory cytokine release.

Dosing Information

Half-Life

4 hours (estimated)

Typical Dose

250–500 mcg

Frequency

1-2x daily

Cycle Length

4-12 weeks

Administration Routes:
subcutaneousintramuscularoral

Benefits

  • Protects gut mucosal immune barrier integrity
  • Reduces immune-mediated intestinal inflammation
  • Counteracts NSAID-induced immune disruption in the GI tract
  • Modulates cytokine balance toward anti-inflammatory profile
  • Supports immune recovery after systemic stress or illness
  • Cytoprotective effects on immune-active tissues

Side Effects

Nausea (rare, mild)mild
Dizziness (rare)mild
Injection site irritationmild
Headache (uncommon)mild

Mechanism of Action

1

Modulates nitric oxide pathways involved in immune signaling

2

Reduces TNF-alpha and other pro-inflammatory cytokine release

3

Protects intestinal epithelial tight junctions from immune-mediated disruption

4

Interacts with the dopaminergic system which cross-talks with immune regulation

5

Promotes angiogenesis to support immune cell trafficking to damaged tissue

Contraindications

Do not use this peptide if any of the following apply:

  • Active cancer (due to angiogenic properties)
  • Pregnancy or breastfeeding
  • History of blood clots (theoretical)

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical
100 studies

Over 100 published studies on BPC-157, many demonstrating immune-relevant effects including cytoprotection, anti-inflammatory activity, and mucosal immune barrier preservation. Phase 2 trials conducted for inflammatory bowel disease. Immune modulation is considered a key secondary mechanism underlying its healing properties. Cross-reference: see bpc-157 in healing-recovery for full tissue repair profile.

Frequently Asked Questions

Common questions about BPC-157 (Immune)

UK-Specific Information

Exclusive data points and guidance for UK residents using BPC-157 (Immune)

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok